The AD cells of both CN and CR patients had very low expression of E-cadherin, while there was an enhanced mean expression of N-cadherin in the AD population of CN patients (∼16-fold, p<0.08) compared to CR patients (Figure 9). This evidence concerns the gene CDH2 and Alzheimer disease.